I Peace在美国推出个性化 iPS细胞服务和长寿治疗方案-动脉网

I Peace Launches Personalized iPS Cell Services and Longevity Treatment in the U.S.

CISION 等信源发布 2025-04-05 20:00



可切换为仅中文







– Age-Reversed Stem Cell Technology Now Available to the Public –

– 年龄逆转干细胞技术现已向公众开放 –

PALO ALTO, Calif.

加利福尼亚州帕洛阿尔托

，

April 5, 2025

2025年4月5日

/PRNewswire/ -- I Peace, Inc. (

https://ipeace.com/en/

https://ipeace.com/zh/

), a global pioneer in iPSC (induced pluripotent stem cell) technology, proudly announces the launch of its personalized iPS cell production and longevity-focused rejuvenation therapies in

），作为iPSC（诱导多能干细胞）技术的全球先锋，自豪地宣布推出其个性化iPS细胞生产和专注于长寿的再生疗法在

the United States

美国

。

在

April 5

4月5日

, Koji will be speaking at the 'Unlimited Health Conference,' a part of the Vitalist Bay, the biggest longevity event in the world that is held in

，小岛将出席“无限健康会议”并发表讲话，该会议是全球最大长寿活动“活力湾”的一部分，举办地点在

Berkeley California

加利福尼亚州伯克利

。

For more information, visit

欲了解更多信息，请访问

https://ipeace.com/en/

https://ipeace.com/zh/

iPS cell technology enables the creation of age-reversed stem cells that reflect a younger version of the individual's biology. I Peace is now expanding the use of this breakthrough not only for regenerative medicine but also for a wide range of longevity applications.

iPS细胞技术能够创造反映个体更年轻生物学状态的年龄逆转干细胞。I Peace正在拓展这一突破性技术的应用，不仅用于再生医学，还广泛应用于长寿领域。

Previously, clinical grade iPS cell production in one facility was limited to just one person per year, with costs reaching a few million USD. I Peace has now achieved industrial-scale manufacturing, capable of producing hundreds of iPS cell lines per year and has reduced the cost to several thousands of dollars per individual..

此前，一个设施内临床级iPS细胞的生产每年仅限于一个人，成本高达几百万美元。如今，I Peace已经实现了工业规模的生产，能够每年生产数百个iPS细胞系，并将成本降低到每人几千美元。

Conventional stem cells retain the age of the donor — a 50-year-old person's stem cells still retain the characteristics of 50 years old. In contrast, iPS cells enable the extraction of youthful cellular components, making it possible to develop therapies based on the individual's own cells but in a younger state.

传统干细胞保留了捐赠者的年龄——一个50岁人的干细胞仍然具有50岁的特征。相反，iPS细胞能够提取年轻的细胞成分，从而可以开发基于个人自身细胞但处于更年轻状态的疗法。

Scientific studies suggest that restoring youthful cellular factors may significantly promote rejuvenation and extend vitality..

科学研究表明，恢复年轻的细胞因子可能显著促进再生并延长活力。

With this capability, I Peace is delivering what was once impossible: personalized access to one's own age-reversed cells for use in advanced longevity and rejuvenation therapies. Furthermore, because iPS cells can differentiate into virtually any human cell, they serve as a biological backup — offering the potential to treat disease or injury in the future using the patient's own youthful cells..

通过这一能力，I Peace 正在实现曾经不可能的事情：为个人提供自身逆龄细胞的定制化获取，用于先进的长寿和再生疗法。此外，由于 iPS 细胞几乎可以分化为任何人类细胞，它们充当了生物学备份——未来有可能使用患者自身年轻的细胞来治疗疾病或损伤。

I Peace now offers two core services in the U.S.:

我和平现在在美国提供两项核心服务：

Personal iPS Cell Production & Banking – Create and preserve your own youthful stem cells while you're still healthy.

个人iPS细胞生产与存储——在您仍然健康时，创造并保存您年轻的干细胞。

Longevity & Rejuvenation Therapies – Personalized therapeutic applications using age-reversed cells and their components.

长寿与再生疗法——使用年龄逆转细胞及其成分的个性化治疗应用。

These services have already been provided to hundreds of individuals in

这些服务已经提供给了数百人

Japan

日本

, and I Peace is now making them available to clients in the U.S.

，现在和平正在让它们提供给美国的客户。

'We aim to bring the power of iPS cell technology to everyone — so people can take charge of their own longevity and unlock a healthier, longer life,' said

“我们的目标是将iPS细胞技术的力量带给每个人——让人们能够掌控自己的长寿之路，解锁更健康、更长寿的人生，”表示

Koji Tanabe

田辺浩二

, Founder and CEO of I Peace.

I Peace创始人兼首席执行官。

I Peace, Inc.

和平公司

I Peace, Inc. provides GMP iPS cells globally and is an entrusted manufacturing service provider of various medical grade cells. The company was founded in 2015 by

I Peace公司向全球提供GMP级别的iPS细胞，并且是各种医用级细胞的委托生产服务商。该公司于2015年由创始人成立。

Koji Tanabe

田辺浩二

, a graduate of Professor

，教授的毕业生

Shinya Yamanaka's

山中伸弥的

laboratory at

实验室在

Kyoto University

京都大学

, and the second author of the paper that reported the successful establishment of the world's first human iPS cell line. Tanabe has been involved in iPS cell research since the early days of its development and is working daily on innovative technical developments to make iPS cells accessible to everyone through I Peace, Inc..

，以及报道成功建立世界上第一条人类iPS细胞系的论文的第二作者。田边自iPS细胞研究早期就参与其中，并且每天都在通过I Peace公司进行创新的技术开发，致力于让每个人都能够使用iPS细胞。

Our unique technology enables us to produce multiple donor-derived iPS cells in parallel without contamination concerns and to provide scalable iPS cell manufacturing at a reasonable price. We are also promoting the production of iPS cells for individuals so that everyone in the world can prepare for the future by preserving their own iPS cells..

我们的独特技术使我们能够并行生产多个供体来源的诱导多能干细胞（iPS细胞），而无需担心污染问题，并以合理的价格提供可扩展的iPS细胞生产。我们还致力于推动个人iPS细胞的生产，以便世界上每个人都可以通过保存自己的iPS细胞为未来做好准备。

We support drug discovery and cell medicine development by providing iPS cells and other cell products that meet PMDA and FDA standards to pharmaceutical and cell medicine development companies so that cell medicine can become available to patients as soon as possible. Our ultimate goal is to enhance the prevalence of regenerative medicine by establishing iPS cell banking services for individuals and making iPS cells accessible to other development companies working with this incredible technology..

我们通过向制药和细胞医药开发公司提供符合PMDA和FDA标准的iPS细胞及其他细胞产品，来支持药物发现和细胞医学的发展，从而使患者能够尽快受益于细胞治疗。我们的最终目标是通过为个人建立iPS细胞库服务，并使其他从事这项卓越技术的开发公司能够获取iPS细胞，进而推动再生医学的普及。

I Peace, Inc.

和平公司

Founder & CEO:

创始人兼首席执行官：

Koji Tanabe

田边宏治

Established: 2015

成立时间：2015年

Headquarters:

总部：

Palo Alto, California